Global Stem Cells Group Subsidiary Stem Cell Center Network Announces Expansion to Escazú, Costa Rica
Image: CIMA Hospital in Escazú
Global Stem Cells Group announces plans to expand its Stem Cell Center Network to include a new stem cell treatment center in Escazú, Costa Rica.
MIAMI, Dec. 21, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, has announced the opening of a new stem cell center in its Stem Cell Center Network in Escazú, Costa Rica. The new center will focus on treating patients who suffer from regenerative illnesses.
The new center, located at the CIMA Hospital in Escazú, will be headed by Leslie Mesen, M.D., a specialist in anti-aging medicine.
The new center is part of Global Stem Cells Group’s worldwide expansion of its clinical presence, partnering with qualified physicians experienced in stem cell therapies to open new clinics and utilize GSCG stem cell products and protocols inpatient treatments. GSCG has established similar alliances in 33 cities worldwide.
The new center’s location at the CIMA Hospital in Escazú offers a safe and luxurious venue for patients traveling from the U.S. and other countries for treatment.
Mesen studied medicine at the Ibero-American University (UNIBE) in San José, Costa Rica. He leads numerous regenerative medicine courses in the United States and throughout Latin America. He is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine.
Mesen has served as chief medical officer of three highly-recognized anti-aging institutes, including the Costagenics Age Management program (2007-2010), Anti-Aging Institute of the Americas (2010-2013) and the Anti-Aging and Wellness Clinic (2014-present).
The new center in Escazú is equipped with the latest, cutting-edge regenerative medicine technology. Mesen was trained in Global Stem Cells Group facilities in the U.S.
“This new center, headed by Dr. Mesen, is a perfect reflection of Global Stem Cells Group’s commitment to meet the growing needs of clients and patients,” says GSCG founder and CEO Benito Novas. “Together with Dr. Mesen, we will continue to provide the latest medical technology and benefits available through our regenerative medicine products and protocols.
Global Stem Cells Group hopes to approve five more franchises in early 2108. If you are a pysician interested in learning more about joining the world’s largest regenerative medicine practitioner network please contact us www.stemcellcenter.net
GSCG provides stem cell treatments for a variety of conditions, diseases, and aesthetic treatments at facilities worldwide. The new facility will have an international staff experienced in administering the leading cellular therapies available.
Global Stem Cells Group’s Escazú clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
GSCG is committed to providing the highest standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
To learn more about Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 533
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cell Group’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
Escazú, Costa Rica.
- Published in Press Releases
Global Stem Cells Group Research Director Martiza Novas Recognized for Her Work in Regenerative Medicine
Global Stem Cells Group Research Director Martiza Novas Recognized for Her Work in Regenerative Medicine
MIAMI, Dec. 22, 2017—Maritza Novas Research Director, Global Stem Cells Group, earned recognition for her work and achievements in regenerative medicine at the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity, Dec. 2, 2017, in Mexico City.
Novas has been in the forefront of medical and anti-aging medicine since 2001. The recognition, signed and presented to her by Congress President Rector Doctor Arturo Conde at the event, honored her for 10 years of dedicated service educating others on clinical applications of stem cells.
A pioneer in the use of stem cells for therapeutic procedures, pain management, and treatment of chronic degenerative conditions, Novas has trained more than 2,000 physicians worldwide on procedures and protocols for harvesting and isolating adipose-derived stem cells for autologous re-implantation, and with problem-solving methods to improve patient outcomes.
Novas specializes in stem cell procedures for anti-aging applications, tissue regeneration, functional medicine, age management, bio-identical hormone therapy, and weight control. Novas has been a certified ISSCA specialist for more than four years.
As a member of Stem Cell Training, Inc.’s research and development team, Novas has assisted in the development of new proprietary adipose and bone marrow protocols currently being used in the company’s comprehensive stem cell training courses.
Novas earned a medical degree at the University of Havana, Cuba in 1993. Novas, Director of Research and Development for Global Stem Cells Group, has been in the forefront of medical and anti-aging medicine since 2001.
She has been a member of the American Academy of Anti-Aging Medicine since 2004 and draws upon 10 years of combined experience with therapeutic procedures, hormonal replacement and nutritional therapies, liposculpture, and fat transfers. Novas is currently completing a master’s degree in Molecular Biology at Lehigh University.
For more information, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Maritza Novas recognized
- Published in Press Releases
Global Stem Cells Group Announces Relaunch of StemData Cloud-Based Practice Management System
Global Stem Cells Group has announced the relaunch of its StemData cloud-based electronic medical record system specifically designed for regenerative medicine practitioners.
MIAMI, Nov. 29, 2017—Global Stem Cells Group, a world leader in stem cell and regenerative medicine, has announced the relaunch of its StemData software, the first cloud-based electronic medical record system specifically designed for regenerative medicine practitioners.
The StemData system, initially launched in September 2016, is a customized software program for physicians who operate a regenerative medicine practice. The StemData software empowers physicians to follow patients throughout their treatment schedules. The StemData program comes programmed with the latest point-of-care regenerative medicine protocols and follow-up procedures to make it easy for stem cell patients to schedule appointments by phone, and for practitioners to document patient progress and gather important data to establish the safety and efficacy of stem cell treatments in the physician’s office environment.
The StemData system app is marketed exclusively through Global Stem Cells Group and will be provided free of charge to affiliate physicians in the Stem Cell Center network.
StemData’s cloud-based, server-less solution is accessible via web, iPad, iPhone, Google Glass and Apple Watch. Global Stem Cells Group has utilized the development of the latest electronic medical record (EMR) systems to bring intelligent EMR technology to regenerative medicine specialists.
The StemData app helps regenerative medicine practitioners increase efficiencies in their medical practices while improving both treatment and business outcomes. The app will intuitively adapt to each individual practitioner’s unique practice preferences.
To learn more about GSCG’s StemData solution, visit http://www.stemdata.org, email info@stemcellsgroup.com, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cell Group’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
stemdata relaunch
- Published in Press Releases
ISSCA Announces New Stem Cell Center Location in Buenos Aires
The International Association for Stem Cell Application moved to a new office at Piedra 383 at Ciudad Autonoma of Buenos Aires, Argentina. The move accommodates ISSCA’s increasing specialty and patient volume, as well as its expanding regenerative medicine certification training programs.
MIAMI, Nov. 29, 2017—The International Association for Stem Cell Application (ISSCA) has announced the move of its Puerto Madero office in Buenos Aires to a new location just a few blocks away to Piedra 363. The new location will house an ISSCA regional office and treatment center.
ISSCA Buenos Aires
The move to the larger office reflects ISSCA’s need to accommodate rapidly expanding patient volume and specialty offerings at its Buenos Aires center. The larger clinical and office space will allow ISSCA to continue providing superior services to patients traveling from the U.S, and worldwide for regenerative medicine treatments. The new location includes a dedicated conference room to host ongoing regenerative medicine training programs and more than three new procedure rooms.
ISSCA celebrated the new location’s grand opening Nov. 26-27, 2017, and host ISSCA regenerative medicine certification training courses for physicians.
To learn more about the ISSCA’s Buenos Aires center and training courses, visit the ISSCA website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
ISSCA Buenos Aires
- Published in Press Releases
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East
Magellan Autologous Platelet Separator
MIAMI, Nov. 29, 2017— Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, and its subsidiary Adimarket have been named to represent the Magellan Autologous Platelet Separator in Latin America and Middle East.
Developed by Arteriorcyte Medical Systems, a leading medical device company headquartered in Hopkinton, Mass., the Magellan Autologous Platelet Separator is a high-tech, automated dual spin processing system designed for use in clinical laboratories or intraoperatively at the point-of-care for safe and rapid preparation of high-quality, platelet-rich plasma (PRP) as well as platelet poor plasma (PPP).
Global Stem Cells Group CEO Benito Novas says the Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.
“We share Arteriocyte’s commitment to research and development of blood component technology to advance treatments that benefit patients in the field of regenerative medicine,” Novas says. “The Magellan system furthers GSCG’s drive to invest in platelet separation technologies that focus on the development of new surgical applications for PRP and elevates these technologies to the next level.”
The fully-automated Magellan system is specifically designed to fractionate blood at bedside without a need for manual manipulation. At the end of its cycle, the Magellan PRP is delivered into a collection syringe, ready for immediate application.
As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations. The system can be programmed to deliver a volume of 3 – 10 mL from each processing cycle, allowing practitioners to customize the concentration per mL within the PRP. The Magellan system is approved for three processing cycles per disposable separation chamber, allowing for a maximum of 30 mL of product.
For more information, visit the Adimarket regenerative medicine online store website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
About Arteriorcyte Medical Systems:
Arteriocyte Medical Systems, Inc. is a leading medical device company committed to developing and marketing novel medical products to help patients heal faster. Established in 2007 by Arteriocyte, Inc. and DW Healthcare Partners, Arteriocyte Medical Systems is devoted to providing innovative solutions to patients and medical professionals to address serious unmet medical needs particularly in cardiac, orthopedic and vascular surgeries.###
Magellan Autologous platelet separator
- Published in Press Releases
Global Stem Cells Group to Sign Strategic Alliance with BioTrend, Turkey
Global Stem Cells Group announces plans to sign a strategic alliance with BioTrend Turkey, an innovative biotechnology company focused on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies.
MIAMI, Nov. 20, 2017— Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announced plans to sign a strategic alliance with international biotechnology company BioTrend, which services the Turkish health sector.
GSCG’s goals for the alliance are three-fold:
- Organize Turkey’s first International Society for Stem Cell Application (ISSCA) regenerative medicine symposium in April 2018, in Istanbul.
- Host two hands-on regenerative medicine certification training courses per year in Turkey.
- BioTrend will promote and distribute Adimarket regenerative medicine equipment and supplies in the region.
The two-day, hands-on training courses were developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow. Coursework will focus on stem cell technologies and regenerative medicine protocols. Participating physicians learn skills that can be used to treat patients in their practices, and for career advancement.
“This new alliance with BioTrend is a great opportunity to advance the benefits of stem cell medicine in Turkey,” says Global Stem Cells Group CEO Benito Novas. “Turkey’s geographic location bridges Europe and Asia, allowing GSCG to have a widespread influence in establishing our regenerative medicine presence in both Europe and Asia.
“We are excited to work with BioTrend’s innovative team, and move one step closer to establishing Global Stem Cells Group as the leader in regenerative medicine therapies worldwide.”
The alliance is part of Global Stem Cells Group’s push to highlight Turkey’s appeal as a destination for patients seeking stem cell therapies for a variety of conditions.
Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
To learn more about the Global Stem Cells Group Symposium in Istanbul, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About AdiMarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
About BioTrend:
BioTrend was established in Cleveland, Ohio, in 2004, and has been serving the Turkish health sector since 2005. As part of the textile and construction company group, BioTrend benefits from the group`s 25 years of international business experience to move forward stronger and more professionally.
BioTrend focuses on genetic, biochemistry, molecular biology, biomaterials and stem cell technologies; the company has introduced a significant number of innovative technologies to the Turkish healthcare industry. The technologies and products which are safe, high technology and proved their quality in the world are marketed and distributed by BioTrend in Turkey.
- Published in Press Releases
ISSCA Announces First 2018 Regenerative Medicine Certification Training Course in Miami, Feb. 2-3, 2018.
ISSCA will conduct the first regenerative medicine certification training course for the upcoming year in Miami Feb. 2-3, 2018. The two-day course focuses on pain management and aesthetic regenerative medicine protocols.
MIAMI, Nov. 20, 2017—The International Society for Stem Cell Application (ISSCA) announced plans to hold its first regenerative medicine certification training course of the upcoming year Feb. 2 – 3, 2018 in Miami.
The two-day, hands-on training course focuses on pain management and aesthetic regenerative medicine protocols. Practitioners learn skills that can be used to treat patients in their practices, and for career advancement. The course provides participating physicians with training in stem cell applications to benefit patients undergoing aesthetic procedures or being treated for specific medical condtions.
Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.
The ISSCA pain management and aesthetic regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow.
Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
To learn more about the training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
ISSCA to Conduct Regenerative Medicine Certification Training Dec. 2-3, 2017, in Mexico City
ISSCA announced plans to conduct a regenerative medicine certification training course for qualified physicians following the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity in Mexico City.
MIAMI, Nov. 20, 2017—The International Society for Stem Cell Application (ISSCA) announced plans to hold a stem cell training certification course Dec. 2 – 3, 2017, following the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity in Mexico City. The training course will be ISSCA’s first opportunity to teach participating physicians how to use the new SEMPIA SVF Isolation Kit, a new product from Adimarket designed for quicker, simpler isolation and concentration of SVF derived from adipose tissue.
The two-day, hands-on training course covers the latest technology and procedures in SVF and bone marrow stem cell techniques. Practitioners learn skills that can be used to treat patients in their practices, and for career advancement. Coursework includes:
- Concepts of cellular and molecular biology
- Cellular therapy
- Reciprocal protocols of adult stem cells
- Extraction and insulation techniques of adipose tissue-derived cells
- Extraction and insulation techniques of bone marrow derivative cells
The ISSCA SVF and bone marrow training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from adipose tissue and bone marrow.
The stem cell training certification course will be held at the Stem Cell Center in Mexico City as part of the post-congress activities.
To learn more about the training course and register to participate, visit the Stem Cell Course Mexico City website, email info@stemcellsgroup.com, or call 305-560-5337.
Since 2014, Global Stem Cells Group has joined forces with some of the most prestigious regenerative medicine practitioners in South America as it focuses on growing its services throughout the global community. Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
Ernesto Miguel Delgado Cidranes, M.D., Ph.D., Named Director of ISSCA Chapter in Europe
Ernesto Miguel Delgado Cidranes, M.D., Ph.D., appointed regional director of ISSCA chapter in Europe.
MIAMI, Nov. 22, 2017—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Ernesto Miguel Delgado Cidranes, M.D., Ph.D., Regional Director of the ISSCA chapter in Europe.
Cidranes is an anesthesiologist and resuscitation and intensive care specialist in, Madrid, Spain. He is a renowned expert in pain management and promotes an integrative and interdisciplinary approach to the treatment of pain. Cidranes’s areas of expertise include interventional pain management, pain treatment, stem cell therapies, and regenerative medicine.
As the European regional director, Cidranes will promote ISSCA activities in EU, and collaborate with the organization to establish new standards for regenerative medicine protocols worldwide. Cidranes will conduct a specialized training workshop in pain management and cosmetic gynecology Feb. 25-26, 2018 in Madrid, Spain, and plans to promote the workshop throughout Europe.
He is director, CEO, and founder at Advanced Pain and Aesthetic Management Center in Madrid, and serves on the advisory board for ISSCA affiliate Global Stem Cells Group. Cidranes is also head of service at the La Milagrosa Hospital Pain Unit and the Pain Unit Los Madronas Hospital, both in Madrid.
He serves as a medical specialist in anesthesiology-reanimation and pain therapy at the Hospital Ramon y Cajal in Madrid, and an editorial board member of the Journal Pain Management and Therapy. Cidranes is also a popular international speaker on pain management, stem cell therapies, regenerative medicine, and ultrasound techniques.
“It is a pleasure to have Dr. Cidranes representing ISSCA in Europe, and as a collaborator in our efforts to establish new regenerative medicine standards worldwide,” He brings a wealth of experience and expertise to the ISSCA organization.”
To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
Alfredo Hoyos, M.D. Appointed Director of ISSCA Chapter in Venezuela, Colombia, Ecuador, and Peru
Alfredo Hoyos, M.D., appointed regional director of ISSCA chapter in Venezuela, Colombia, Ecuador, and Peru.
MIAMI, Nov. 22, 2017—The International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., announced the appointment of Alfredo Hoyos, M.D., Regional Director of the ISSCA chapter in Venezuela, Colombia, Ecuador, and Peru.
As regional director, Hoyos will promote ISSCA activities in those countries and collaborate with the organization to establish new standards for regenerative medicine protocols. Hoyos will be in charge of organizing two hands-on stem cell training courses to be held in Bogota March 2-3 and July 6-7, 2018. Hoyos will also be in charge of the International Regenerative Medicine Symposium to be held in Bogota in July, 2018.
Hoyos is a world-renowned board-certified plastic surgeon from Bogota, Colombia, specializing in aesthetic plastic surgery, maxillofacial surgery, and hand surgery. He earned his medical degree from El Rosario University, Colombia, and completed visiting fellowships in aesthetic surgery at New York University, in maxillofacial surgery at Mount Sinai Hospital in New York, and in facial aesthetic surgery at Manhattan Eye, Ear and Throat Hospital in New York. He serves as chief scientific officer for ISSCA affiliate Global Stem Cells Group in Miami.
Hoyos invented high definition liposculpture (HDL) and dynamic definition in lipoplasty (4D) techniques, as well as other advanced techniques focused on body contouring. He has also refined techniques in fat transfer (buttock and pectoral lipograft) and breast augmentation.
“We are proud to have Dr. Hoyos representing ISSCA in South America, and look forward to working with him to promote ISSCA pursuits,” says Kim. “His expertise will significantly enhance our collaborative efforts to establish new standards for regenerative medicine protocols worldwide.”
To learn more about the ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
